Objective: Oxidized phospholipids (OxPL), such as the oxidized derivatives of 1-palmitoyl-2-
arachidonoyl-sn-glycero-3-phosphorylcholine, 1-palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3 …

Oxidation of atherogenic low-density lipoproteins (LDL) plays a key role in the pathogenesis
of atherosclerosis. Oxidation stress and inflammation are closely interrelated and they can …

Despite the strong association between antiphospholipid antibodies (aPL) and thrombosis,
the pathogenic role of aPL in the development of thrombosis has not been fully elucidated …

Anti-phospholipid autoantibodies are a group of antibodies that can specifically bind to
anionic phospholipids and phospholipid protein complexes. Recent studies have reported …

Currently, the origin of autoimmune diseases is considered to be multifactorial. Genetic
predisposition, immune system malfunction or even backfire, hormonal regulation, and …

The antiphospholipid syndrome (APS) is a systemic autoimmune disease characterized by
an adaptive immune response against self-PL-binding proteins ending in the production of …

The antiphospholipid syndrome (APS) has occupied haemostaseologists, rheumatologists
and obstetricians since its initial description 35 years ago. Its name has been coined …

Antiphospholipid syndrome (APS) is an autoimmune disorder characterized by the presence
of antiphospholipid antibodies (aPL)(lupus anticoagulant, anticardiolipin antibodies and anti …

Sphingosylphosphorylcholine (SPC) is a component of high-density lipoprotein particles.
We investigated the functional role of SPC in HUVECs. SPC stimulation induced production …

The antiphospholipid syndrome (APS) is a noninflammatory autoimmune disease defined by
the presence of antiphospholipid autoantibodies (aPL) in plasma of patients with venous …